Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madeleine Birgersson

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Cancer|October 23, 2025
Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)-associated tonsillar squamous cell carcinoma (TSCC)Tobias Näsman, Madeleine Birgersson, Linda Marklund, et al.
International Journal of Molecular Sciences|September 23, 2022
Colitis Induces Sex-Specific Intestinal Transcriptomic Responses in MiceLinnea Hases, Madeleine Birgersson, Rajitha Indukuri, et al.
Molecular and Clinical Oncology|February 11, 2026
Prognostic impact of HLA class I immunohistochemistry staining intensity with regard to the risk of recurrence of adenoid cystic carcinomaMark Zupancic, Madeleine Birgersson, Signe Friesland, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 4, 2022
Antibody Validation for Estrogen Receptor BetaMadeleine Birgersson, Borbala Katona, Cecilia Lindskog, et al.
Molecular Oncology|February 24, 2026
Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell modelMonika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, et al.
Anticancer Research|October 28, 2025
Fibroblast Supernatants Modulate Treatment Responses in Human Papillomavirus Positive and Negative Oropharyngeal Cancer Cell LinesMadeleine Birgersson, Terézia Chabanová, Emilia Wiechec, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 26, 2024
Enhancing targeted therapy by combining PI3K and AKT inhibitors with or without cisplatin or vincristine in medulloblastoma cell lines in vitroMonika Lukoseviciute, Emma Need, Madeleine Birgersson, et al.
Endocrinology|April 19, 2023
ERβ in Granulosa Cell Tumors and Its Clinical PotentialMadeleine Birgersson, Rajitha Indukuri, Per Antonson, et al.
The Science of the Total Environment|October 30, 2020
Benchmarking virus concentration methods for quantification of SARS-CoV-2 in raw wastewaterMohammed Hakim Jafferali, Kasra Khatami, Merve Atasoy, et al.
International Journal of Cancer|August 29, 2025
Age and tumour presentations differ between HPV type 16 positive and other high-risk HPV type-positive oropharyngeal squamous cell carcinomas in a Swedish cohort of 2000-2022Anders Näsman, Madeleine Birgersson, Tobias Näsman, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|October 23, 2025
Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)-associated tonsillar squamous cell carcinoma (TSCC)Tobias Näsman, Madeleine Birgersson, Linda Marklund, et al.
International Journal of Molecular Sciences|September 23, 2022
Colitis Induces Sex-Specific Intestinal Transcriptomic Responses in MiceLinnea Hases, Madeleine Birgersson, Rajitha Indukuri, et al.
Molecular and Clinical Oncology|February 11, 2026
Prognostic impact of HLA class I immunohistochemistry staining intensity with regard to the risk of recurrence of adenoid cystic carcinomaMark Zupancic, Madeleine Birgersson, Signe Friesland, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 4, 2022
Antibody Validation for Estrogen Receptor BetaMadeleine Birgersson, Borbala Katona, Cecilia Lindskog, et al.
Molecular Oncology|February 24, 2026
Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell modelMonika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, et al.
Anticancer Research|October 28, 2025
Fibroblast Supernatants Modulate Treatment Responses in Human Papillomavirus Positive and Negative Oropharyngeal Cancer Cell LinesMadeleine Birgersson, Terézia Chabanová, Emilia Wiechec, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 26, 2024
Enhancing targeted therapy by combining PI3K and AKT inhibitors with or without cisplatin or vincristine in medulloblastoma cell lines in vitroMonika Lukoseviciute, Emma Need, Madeleine Birgersson, et al.
Endocrinology|April 19, 2023
ERβ in Granulosa Cell Tumors and Its Clinical PotentialMadeleine Birgersson, Rajitha Indukuri, Per Antonson, et al.
The Science of the Total Environment|October 30, 2020
Benchmarking virus concentration methods for quantification of SARS-CoV-2 in raw wastewaterMohammed Hakim Jafferali, Kasra Khatami, Merve Atasoy, et al.
International Journal of Cancer|August 29, 2025
Age and tumour presentations differ between HPV type 16 positive and other high-risk HPV type-positive oropharyngeal squamous cell carcinomas in a Swedish cohort of 2000-2022Anders Näsman, Madeleine Birgersson, Tobias Näsman, et al.
Pageof 2